Literature DB >> 10415743

Matrix metalloproteinase inhibition. From the Jurassic to the third millennium.

J F Woessner1.   

Abstract

A brief historical introduction to the matrix metalloproteinase (MMP) field, which began in 1962, is followed by an overview of the inhibition of these proteases by natural inhibitors such as alpha 2 macroglobulin and the TIMPs (tissue inhibitors of metalloproteinases) and by synthetic inhibitors, which are largely chelating agents. The latter include thiol, alkylcarbonyl, phosponamidate and hydroxamate compounds, as well as the tetracyclines. A review of the most recent progress concludes with prognostications as to where the field may be going next.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10415743     DOI: 10.1111/j.1749-6632.1999.tb07697.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  23 in total

Review 1.  Matrix metalloproteinase biology applied to vitreoretinal disorders.

Authors:  C S Sethi; T A Bailey; P J Luthert; N H Chong
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

2.  Salivary histatin 5 is an inhibitor of both host and bacterial enzymes implicated in periodontal disease.

Authors:  H Gusman; J Travis; E J Helmerhorst; J Potempa; R F Troxler; F G Oppenheim
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

Review 3.  The paradox of matrix metalloproteinases in infectious disease.

Authors:  P T G Elkington; C M O'Kane; J S Friedland
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

4.  Matrix metalloproteinases (MMP-2 and MMP-9) activity in corneal ulcer and ocular surface disorders determined by gelatin zymography.

Authors:  Arti Singh; O P S Maurya; M V Jagannadhan; Ashok Patel
Journal:  J Ocul Biol Dis Infor       Date:  2012-12-29

5.  Association of MMP3 and TIMP2 promoter polymorphisms with nonsyndromic oral clefts.

Authors:  Ariadne Letra; Renato M Silva; Luise G Motta; Susan H Blanton; Jacqueline T Hecht; Jose M Granjeirol; Alexandre R Vieira
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-06-22

Review 6.  Protease-activated receptors in hemostasis.

Authors:  Marvin T Nieman
Journal:  Blood       Date:  2016-04-28       Impact factor: 22.113

7.  Addition of zinc methacrylate in dental polymers: MMP-2 inhibition and ultimate tensile strength evaluation.

Authors:  Sandrina Henn; Rodrigo Varella de Carvalho; Fabrício Aulo Ogliari; Ana Paula de Souza; Sergio Roberto Peres Line; Adriana Fernandes da Silva; Flávio Fernando Demarco; Adriana Etges; Evandro Piva
Journal:  Clin Oral Investig       Date:  2011-03-30       Impact factor: 3.573

8.  Family-based association study of matrix metalloproteinase-3 and -9 haplotypes with susceptibility to ischemic white matter injury.

Authors:  Myriam Fornage; Thomas H Mosley; Clifford R Jack; Mariza de Andrade; Sharon L R Kardia; Eric Boerwinkle; Stephen T Turner
Journal:  Hum Genet       Date:  2006-09-22       Impact factor: 4.132

9.  Identification, purification and partial characterization of tissue inhibitor of matrix metalloproteinase-2 in bovine pulmonary artery smooth muscle.

Authors:  Malay Mandal; Amritlal Mandal; Sudip Das; Tapati Chakraborti; Sajal Chakraborti
Journal:  Mol Cell Biochem       Date:  2003-12       Impact factor: 3.396

10.  Identification, purification and partial characterization of tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in bovine pulmonary artery smooth muscle.

Authors:  Malay Mandal; Sudip Das; Tapati Chakraborti; Amritlal Mandal; Sajal Chakraborti
Journal:  Mol Cell Biochem       Date:  2003-12       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.